Post-approval studies (Phase 4)UnknownNCT03490994
What this trial is testing
Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)
Who this might be right for
Acute Heart Failure
Yonsei University 150